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ABSTRACT
Objectives To explore associations of night- time light 
intensity (NTLI), a novel proxy for continuous urbanisation 
levels, with mean systolic blood pressure (SBP), body mass 
index (BMI), fasting serum low- density lipoprotein (LDL) 
and fasting plasma glucose (FPG), among adults in early- 
stage urbanisation in Telangana, South India.
Design Cross- sectional analysis of the third wave of the 
Andhra Pradesh Children and Parents Study cohort.
Setting 28 villages representing a continuum of 
urbanisation levels, ranging from rural settlement to 
medium- sized town in Telangana, South India.
Participants Data were available from 6944 participants, 
6236 of whom were eligible after excluding pregnant 
women, participants younger than 18 years of age and 
participants missing data for age. Participants were 
excluded if they did not provide fasting blood samples, had 
implausible or missing outcome values, were medicated 
for hypertension or diabetes or had triglyceride levels 
invalidating derived LDL. The analysis included 5924 
participants for BMI, 5752 participants for SBP, 5287 
participants for LDL and 5328 participants for FPG.
Results Increasing NTLI was positively associated with 
mean BMI, SBP and LDL but not FPG. Adjusted mean 
differences across the range of village- level NTLI were 
1.0 kg/m2 (95% CI 0.01 to 1.9) for BMI; 4.2 mm Hg (95% CI 
1.0 to 7.4) for SBP; 0.3 mmol/L (95% CI −0.01 to 0.7) for 
LDL; and −0.01 mmol/L (95% CI −0.4 to 0.4) for FPG. 
Associations of NTLI with BMI and SBP were stronger in older 
age groups.
Conclusion The association of NTLI with cardiovascular 
disease (CVD) risk factors identify NTLI as a potentially 
important tool for exploring urbanisation- related health. 
Consistent associations of moderate increases in 
urbanisation levels with important CVD risk factors warrant 
prevention strategies to curb expected large public health 
impacts from continued and rapid urbanisation in India.
BACKGROUND
Cardiovascular diseases (CVDs), primarily 
coronary heart disease, are the leading causes 
of death (28%) and disability- adjusted life 
years (14%) in India.1 They occur 5–10 years 
earlier than in Western populations,2 and 
the age- standardised mortality rate (272 per 
100 000 persons) exceeds the global average 
and rates of some high- income countries.3 4 
Individuals and societies in India therefore 
continue to experience substantial losses of 
productivity and income.1 5–7
Urbanisation and CVD risk factors
Urbanisation is often described as a key driver 
of CVDs in low- income and middle- income 
(LMICs) acting on CVDs and their risk factors 
through inter- related changes in social, phys-
ical and build environments, sociodemo-
graphics, lifestyle and mental health. Some 
of these change are associated with harmful 
Strengths and limitations of this study
 ► We used a novel, standardised proxy of continuous 
urbanisation levels, remote sensing data on night- 
time light intensity, measured at the village level.
 ► The villages had experienced rapid uneven urbani-
sation during the decades preceding the study and 
represented a continuum of urbanisation levels 
ranging from a rural settlement to a medium- sized 
town.
 ► The study used a large population- based sam-
ple from 28 urbanising villages at early stages of 
urbanisation.
 ► Differences between excluded and included partic-
ipants warranted some caution of generalising the 
findings to the general population.
 ► The cross- sectional design prevented us from mak-
ing causal inferences or exploring the impact of 
urbanisation rate on cardiovascular diseases risk 
factors.
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impacts on cardiovascular health, for example, due to 
reduced physical activity and nutrition transitions, while 
others may be beneficial, for example, through more 
and better education and access to health and social 
services.8–12 A number of simple rural–urban compar-
isons and migration studies provide insight to the asso-
ciation of urbanisation level with CVD risk factors, such 
as overweight and obesity, hypertension, diabetes and 
dyslipidaemia.8 13–21 The broad rural–urban dichotomies 
are useful, however insufficient, for exploring which 
factors of urbanisation are most important for health in 
LMICs.22 This is in part because no universal definition 
exists of ‘rural’ and ‘urban’ environments, and data on 
neighbourhood characteristics are often not available 
from these settings.22 Furthermore, residents’ character-
istics tend to be more similar within than between urban 
and rural areas. For example, urban residents may on 
average enjoy wider access to goods and services, higher 
levels of education, occupation, affluence and so on, 
whereas the opposite may be the case in rural areas.22 23 
Such limited discordance at either end of the urbanisa-
tion continuum makes it difficult to tease out the under-
lying mechanisms of observed differences in CVD risk 
between the two extremes. Urbanisation factors may 
change at different rates with urbanisation,22 however, 
and thus vary widely across the continuum from rural to 
urban areas. It may therefore be more useful and infor-
mative to study the impact of urbanisation level on CVD 
risk factors in transitioning populations, that is, popula-
tions representing various levels of urbanisation across 
the continuum, where the underlying mechanisms may 
be easier to separate. Unfortunately, it is challenging to 
accurately measure urbanisation as a continuum, whether 
using single- component (eg, population density) or 
multicomponent classification systems (eg, housing types 
and densities, economic activities, physical environment 
and services).22 This is particularly true in LMICs where 
these types of data are often scarce.
Night-time light intensity (NTLI) as a measure of urbanisation 
level
As an alternative to physical data- based scales, remote 
sensing data have been widely used to characterise 
urban landscapes and scale of urbanisation.24 25 The 
NTLI data, obtained by the USA’s Defence Meteorolog-
ical Satellite Programme’s Operational Linescan System, 
are suggested a valid proxy for urbanisation level and 
dynamics due to their strong and consistent relation-
ships with demographic and economic indicators of 
urbanisation such as urban build up area, population 
density, economic activity and energy consumption at 
global, regional and local levels.24–27 The NTLI data, 
which have near global coverage and a freely available 
historical data archive dating back to 1992,28 offer a 
unique opportunity to study the association of urbanisa-
tion, measured by a single standard measure worldwide, 
with CVD risk.
Study aim to address evidence gaps
This study aimed to explore associations of urbanisation 
level (measured by a continuum of NTLI) with mean 
levels of four leading risk factors for CVDs, systolic blood 
pressure (SBP), body mass index (BMI), fasting serum 
low- density lipoprotein (LDL) and fasting plasma glucose 
(FPG), in adults from 28 villages in rapidly urbanising 
Telangana, South India. Improved understanding of the 
association of urbanisation level and CVD risk factors 
in settings that are transitioning from rural areas to 
greater levels of urbanisation will help inform policy for 
disease prevention and control. Such policies are imper-
ative in India, where economic growth and urbanisation 
continues, to avoid further adverse economic and social 
impacts of (premature) CVD morbidity and mortality.
MATERIALS AND METHODS
Study design, setting and participants
The current cross- sectional study analysed data from the 
third and most recent survey wave of the Andhra Pradesh 
Children and Parents Study (APCAPS)29 and was set in 28 
villages near Hyderabad in Telangana, South India. The 
APCAPS birth cohort was originally established (in 2003–
2005) to investigate the short- term and long- term effects 
of early life nutrition on CVDs and their risk factors as 
a long- term follow- up of the Hyderabad Nutrition Trial 
(HNT). The HNT (1987–1990) was a cluster- randomised 
community trial, in which all pregnant women and young 
children received (15 villages) or awaited (14 villages) a 
nutrition intervention. The APCAPS villages experienced 
uneven rates of urbanisation over time, and from the 
second survey wave, the cohort was expanded to include 
more participants and information on CVD risk factors 
to investigate diverse environmental, lifestyle and meta-
bolic risk factors for CVDs in the birth cohort as well as 
among the children’s parents and siblings.30 31 The third 
and most recent data wave (conducted in 2010–2012, 
n=6944 [n
(index children)
=1360; n
(mothers)
=1379; n
(fathers)
=1140; 
n
(siblings)
=2344; n
(general population)
=721]) was selected for cross- 
sectional analysis due to its large adult population (≥18 
years), wide age range and varying levels of urbanisation. 
Details on the recruitment of APCAPS participants from 
the first to the third wave of the APCAPS are presented 
in figure 1. Further details on the cohort are reported 
elsewere.30 31
Sample size and selection
All non- pregnant adults (18 years or older) from the 
third APCAPS survey wave were eligible for inclusion 
(n=6236/6944) (figure 1). Participants who reported 
taking medication for outcome- related conditions were 
excluded to reduce the risk of biasing results, for example, 
towards the null if participants with medically controlled 
blood pressure sustained high levels of risk factors for 
hypertension. Participants were excluded from analyses 
of glucose if they reported fasting for less than 8 hours at 
the time of giving the blood (n=366) or were currently 
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taking medication (tablets or insulin) for diabetes 
(n=94). Participants were excluded from analysis of LDL 
if they reported fasting for less than 9 hours (n=364) or 
had triglyceride levels above 400 mg/dL32 (n=92). Partic-
ipants who reported taking antihypertensive medication 
were excluded from analyses of SBP (n=197) (figure 1). 
One of the 28 surveyed villages was significantly larger 
and had a considerably higher NTLI value than the other 
villages, and its participants were excluded (n=297) to 
avoid over- reliance of results from this outlier village. 
The final sample sizes by study outcome are presented in 
figure 1.
Data
Data collection and procedures
Trained field staff collected data on health and sociode-
mographic information in the local language, Telugu, 
using semistructured questionnaires. Trained field staff 
and medical doctors performed the clinical assessments 
in local clinics and at the National Institute of Nutrition 
in Hyderabad. Venous fasting (8–12 hours) blood samples 
were collected, separated within 30 min and stored locally 
at −20°C. Biochemical assays were performed using the 
Cobas311 autoanalyser at the Genetics and Biochem-
istry Laboratory at The South Asia Network for Chronic 
Diseases of the Public Health Foundation of India, New 
Delhi. To define APCAPS village boundaries, trained field 
staff performed aerial tracing of Bing satellite imagery, 
using Open Street Map software and GPS- based ground 
surveying during 2012–2013.
The NTLI data, which is collected by the USA’s Defence 
Meteorological Satellite Programme’s Operational 
Linescan System, was obtained online from the National 
Oceanic and Atmospheric administration,33 through the 
Google Earth Engine.34 The raw satellite data is processed 
Figure 1 Sampling and participant flow for the third survey wave of the APCAPS. *The Hyderabad Nutrition Trial (1987–1990) 
included 15 intervention and 14 control villages from the Integrated Child Development Services Scheme (stepped- wedge 
cluster randomised nutrition supplementation trial). APCAPS, Andhra Pradesh Children and Parents Study; BMI, body mass 
index; FPG, fasting plasma glucose; LDL, low- density lipoprotein; SBP, systolic blood pressure.
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into annual averages of the intensity of light emitted from 
the Earth’s surface at night from persistent sources asso-
ciated with human settlement, that is, excluding transient 
light sources such as lightning, fire, aurora, solar and 
lunar light. The processed data are aggregated into 30 
arc seconds grids (equivalent to a resolution of approx-
imately 1 km2 pixels)35 and published as unitless digital 
numbers ranging from 0 (no light) to 63 (light satura-
tion).24 27 We obtained the NTLI imagery.
Defining urbanisation level
Urbanisation is commonly described as the process and 
dynamics of permanent concentration of a population in 
urban settlements and/or the adaption of lifestyles asso-
ciated with urban environments, for example, sedentary 
lifestyle or nutrition trantision.10 11 36 37 Although internal 
migration to urban areas is common in India, most urban-
isation is reported to be driven by the natural growth and 
development of rural areas and their subsequent reclas-
sification into urban settlements.38 The term ‘early- stage 
urbanisation’ represents the early transition of rural 
settlements towards more urbanised physical environ-
ments and ways of life in the absence of development 
into large towns or cities. For the purpose of this study, 
the term ‘urbanisation level’ defines the level of urbani-
sation of a village at the time of survey in 2010–2012, as 
measured by NTLI (described in the following section).
Determining urbanisation levels of APCAPS villages
The data defining village boundaries were overlaid with 
the NTLI grids from 2011 (technical issues with satellite 
sensors prevented the use of NTLI data from 2012).28 
Twenty- four villages were intersected by two or more 
pixels, which in some cases had different NTLI values. 
Therefore, to obtain one NTLI value (urbanisation level) 
per village, we used a super- resolution method to resa-
mple the NTLI images to a higher resolution, before 
summing the unitless digital numbers of pixels within 
or intersecting with the village boundary to produce an 
overall village level. This ensured giving the appropriate 
weighting to each of the pixel values present over each 
village. Finally, the data were calibrated using the ridge-
line sampling regression methods,28 and oversaturation 
of light was removed manually. Since the first survey wave 
in 2003–2005, the 28 APCAPS villages had changed from 
rural agricultural communities with similar NTLI levels to 
represent a continuum of NTLI levels with growing differ-
entiation at higher levels.
Selection of study outcomes
For this analysis, we prespecified the four outcomes, BMI, 
SBP, LDL and FPG, from a number of CVD risk factors 
available in the APCAPS, due to their well- established 
and strong associations with CVDs and their modifiable 
nature.32 39 The selection of continuous outcomes also 
enabled exploration of linear relationships between 
increasing level of NTLI and the CVD risk factors.
Measurement of study outcomes
APCAPS cohort data were collected using standardised 
approaches. Weight was measured twice to the nearest 
0.1 kg with digital weight scales (Seca Leicester 899; Chas-
mors Ltd, London, UK) while wearing light clothing 
and no shoes. Standing height was measured twice to 
the nearest 0.1 cm with a portable stadiometer (Seca 
Leicester Height Measure; Chasmors Ltd, London, UK). 
The two weight and height measurements were averaged, 
and BMI was calculated for the analyses as weight (kg)/
height (m)2. Blood pressure was measured three times at 
the right arm in the sitting position using a digital device 
and appropriate sized cuff (Omron hem 7300; Matsu-
saka Co, Japan). The last two measurements of SBP were 
averaged for the analysis. FPG was assessed on the day 
of sampling by enzymatic glucose oxidase/peroxidase-4- 
aminophenazone- phenol method (Randox Laboratories; 
London, UK). Fasting LDL was derived indirectly using 
the Fridewald- Fredrickson formula: LDL = total choles-
terol – high- density lipoprotein – triglycerides/5 (all 
measures in mg/dL).32 40
Biochemical assays of variables needed to derive study outcomes
Serum total cholesterol and triglycerides were assessed by 
enzymatic methods using cholesterol oxidase- peroxidase-
4- aminophenazone- phenol and glycerol phosphate 
oxidase- peroxidase-4- aminophenazone- phenol (Roche 
Diagnostics GmbH; Mannheim, Germany). High- density 
lipoprotein (used for derivation of LDL) was derived by 
direct method using polyethylene glycol modified choles-
terol esterase, cholesterol oxidase and dextran sulphate 
(Roche Diagnostics GmbH; Mannheim, Germany).
Quality assurance
Trained field staff and medical doctors followed stan-
dardised procedures, and anthropometric equipment 
were calibrated at the start of every clinic. Reproducibility 
of clinical measurements were evaluated by repeating 
measures on a 5% random subsample after 1–3 weeks. 
The consistency was high for all measures with intraclass 
correlation coefficient for anthropometric measure-
ments >0.98, blood pressure >0.85 and biochemical assays 
>0.940.41 The quality of biochemical assays were moni-
tored by the Cardiac Biochemistry laboratory at the All 
India Institute of Medical Sciences, which participates in 
the UK National External Quality Assessment Programme 
and the External Quality Assessment Scheme of Randox 
International.
Patient and public involvement
Study participants (patients) and the public were not 
involved in the design or planning of the study.
Statistical methods
Variables were assessed for outliers, cleaned accord-
ingly and examined for normality. NTLI data were non- 
normally distributed and log- transformed for analysis. To 
preserve study power, we allowed sample sizes to vary by 
outcomes. Mixed effects linear regression models with 
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clustering by household and village were fitted in all anal-
yses to account for the hierarchical nature of the data 
and the sampling strategy. NTLI (log transformed), BMI, 
SBP, LDL, FPG, age and room temperature at clinical 
assessment (the latter for analysis of SBP) were included 
as continuous variables. Gender (women or men), caste 
(general caste, scheduled caste, scheduled tribe, other 
backward class and other), religion (Muslim, Hindu, 
Christian and other), current marital status (married or 
unmarried), season of survey and season of birth (summer 
(March–May), South West monsoon (June–October), 
winter (November–February)) were included as cate-
gorical variables. Study characteristics were presented by 
thirds of ranked NTLI, referred to as low, medium and 
high levels. We evaluated potential confounders for each 
outcome using the double- selection method.42 One final 
set of covariates, identified as potential confounders for 
at least one exposure–outcome relationship, were used 
in analyses of all four outcomes. Level of urbanisation 
may affect CVD risk profiles of different genders and age 
groups differently due to, for example, gender inequality, 
employment patterns and readiness to adopt new life-
styles and behaviours.23 43–45 We therefore tested for 
interaction by gender and age. We did not consider socio-
demographic factors such as education, occupation and 
socioeconomic status as potential confounders or effect 
modifiers due to their importance on the causal pathway 
from urbanisation level to CVD risk factors. We did not 
adjust the main analysis of SBP for room temperature at 
clinical assessment because a large proportion of data was 
missing for this variable (n
(missing)
=2648 (45%)). However, 
a supplementary analysis for room temperature- adjusted 
SBP was presented in the supplementary material.
A sensitivity analysis was performed to assess the influ-
ence of trial status among index children from the HNT. 
A second sensitivity analysis was performed to evaluate 
whether borderline outlier villages (with higher or lower 
observed mean outcomes than the majority of villages) 
influenced regression estimates considerably. Differences 
between included and excluded participants were exam-
ined with χ2 and linear and logistic mixed effects models 
with clustering by village and household. All analyses 
were performed in Stata V.14.
RESULTS
Study characteristics
A total of 6236 non- pregnant adults were eligible for 
inclusion in the current study (90% of the third APCAPS 
survey wave). After removing extremes and participants 
with missing outcome data for specific analyses, the 
final samples came to 5924 participants for BMI, 5752 
participants for SBP, 5287 participants for LDL and 5328 
participants for FPG (figure 1). Approximately half of 
participants were women (table 1). The overall median 
age was 32 years (IQR 24–48), with women on average 
older than men. Men and women most frequently iden-
tified with other backward caste and Hindu religion. 
Women were more likely to be married (76%) than men 
(59%). Village- level NTLI ranged from 61.7 (equivalent 
to 4.1 on the log scale) to 1081.1 (equivalent to 7.0 on the 
log scale). The distribution of sociodemographic charac-
teristics were similar across low, medium and high level 
of NTLI. None of the included (non- medicated) partici-
pants reported ever being diagnosed with heart disease, 
including stroke.
Crude and adjusted association of NTLI with CVD risk factors
Model predicted mean BMI, SBP and LDL increased with 
rising NTLI in crude and adjusted linear models (figure 2 
and table 2). Across the range of NTLI, the fully adjusted 
predicted mean increased 1.0 kg/m2 (95% CI 0.01 to 
1.9, p=0.05) for BMI and 4.2 mm Hg (95% CI 1.0 to 7.4, 
p=0.01) for SBP. The pattern was similar for LDL with a 
fully adjusted predicted mean increase across the range 
of NTLI values of 0.3 mmol/L (95% CI −0.01 to 0.7), 
although the evidence was weak from crude (p=0.06) 
and fully adjusted linear models (p=0.06). There were 
no linear association of NTLI with FPG (fully adjusted 
mean difference across the range of NTLI: −0.01 mmol/L 
(95% CI −0.4 to 0.4, p=0.97).
Model predicted mean SBP was on average 6.1 mm Hg 
(95% CI 5.42 to 6.9, p<0.001) higher among men than 
women, whereas levels of BMI, LDL and FPG did not differ 
by gender. However, there was no statistical evidence of 
gender modifying any of the associations between NTLI 
and the CVD risk factors. There was strong evidence that 
age modified the associations of NTLI with BMI (p<0.001) 
and SBP (p<0.001), but not LDL or FPG. NTLI was not 
associated with BMI or SBP in the younger age groups 
(up to 39 years), whereas the evidence and magnitudes 
of associations from both crude and fully adjusted models 
were stronger in older age groups (from 40 years) than 
predicted in the overall analysis (see online supplemental 
figure 1 and table 1). Online supplemental figure 2 illus-
trates at which levels of NTLI the fully adjusted models 
predicted the greatest probability of associations differing 
by age group. Overall and age- specific results of a supple-
mentary analysis for SBP adjusted for room temperature 
at clinical assessment (n=3160) were similar to the main 
and age- specific SBP analyses (see online supplemental 
tables 2, 3 and figure 3).
Comparing included and excluded participants
Participants who were excluded from the main analysis 
due to missing data, medication use, or high triglyceride 
levels differed in some respects from the analysed partic-
ipants. Excluded individuals were on average older, 
less likely to attend clinical assessment/interview in the 
summer and had higher levels of the four CVD risk factors 
than included individuals.
Sensitivity analyses
A sensitivity analysis among HNT index children (n=1245 
(21% of overall sample); intervention n=622, control 
n=623) did not indicate confounding or interaction by 
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intervention status. In a second sensitivity analysis, we 
removed three borderline outlier villages identified in 
analyses of BMI, SBP and FPG. The results of this sensi-
tivity analysis were consistent with the overall and age- 
stratified main analyses for BMI, SBP and FPG (see online 
supplemental figures 4, 5 and tables 4, 5). However, results 
for SBP (not adjusted for room temperature) were not 
statistically significant at the 95% level. Online supple-
mental figure 6 illustrates at which levels of NTLI the fully 
adjusted sensitivity analysis predicted the greatest proba-
bility of differences in associations of NTLI and CVD risk 
factors by age group.
DISCUSSION
Among 6236 participants, NTLI was associated with 
increased model predicted mean BMI, SBP and 
serum fasting LDL, but not FPG after controlling for 
confounders. We expected younger individuals to more 
readily adopt new lifestyles and behaviours associated 
with urbanisation and CVD risk factors than older indi-
viduals.9 44 This was however not apparent from the data. 
The observed stronger associations of NTLI with BMI 
and SBP in older age groups were likely attributable to 
advancing age.32 Gender did not modify associations.
Table 1 Participant characteristics of APCAPS adults from 27 villages, 2010–2012 (n=5932)
NTLI*, women (n=2753 (46%)) NTLI*, men (n=3179 (54%))
Low Medium High Low Medium High
Night- time light 
intensity (NTLI), median 
(IQR)
138.2 (121–149) 202.4 (185–273) 492.8 (485–753) 138.2 (129–149) 202.4 (185–273) 492.8 (396–753)
Age, median (IQR) 40 (25–46) 40 (25–46) 38 (25–45) 28 (23–51) 29 (24–50) 28 (23–49)
Age group (years), n (%)
  <30 299 (38.7) 372 (38.2) 416 (41.3) 489 (54.5) 595 (52.7) 636 (55.2)
  30–39 85 (11.0) 106 (10.9) 134 (13.3) 57 (6.4) 74 (6.6) 91 (7.9)
  40–49 261 (33.8) 348 (35.8) 348 (34.5) 98 (10.9) 151 (13.4) 154 (13.4)
  50+ 127 (16.5) 147 (15.1) 110 (10.9) 254 (28.3) 309 (27.4) 271 (23.5)
  Total 772 (100) 973 (100) 1008 (100) 898 (100) 1129 (100) 1152 (100)
Caste, n (%)
  General caste 51 (6.6) 79 (9.2) 76 (7.5) 51 (5.7) 89 (8.9) 63 (5.5)
  Scheduled caste 277 (35.9) 375 (43.6) 292 (29.0) 331 (36.9) 428 (42.6) 335 (29.1)
  Scheduled tribe 9 (1.2) 3 (0.4) 5 (0.5) 11 (1.2) 3 (0.3) 7 (0.6)
  Other backward 425 (55.1) 374 (43.5) 628 (62.3) 488 (54.3) 455 (45.3) 739 (64.2)
  Other 9 (1.2) 29 (3.4) 7 (0.7) 17 (1.9) 30 (3.0) 8 (0.7)
  Total 771 (100) 860 (100) 1008 (100) 898 (100) 1005 (100) 1152 (100)
Religion, n (%)
  Muslim 19 (2.5) 37 (4.3) 71 (7.0) 16 (1.8) 45 (4.5) 64 (5.6)
  Hindu 742 (96.2) 786 (91.4) 919 (91.2) 875 (97.4) 931 (92.6) 1079 (93.7)
  Christian 9 (1.2) 37 (4.3) 16 (1.6) 7 (0.8) 29 (2.9) 8 (0.7)
  Other 1 (0.1) 0 (0) 2 (0.2) 0 (0) 0 (0) 1 (0.1)
  Total 771 (100) 860 (100) 1008 (100) 898 (100) 1005 (100) 1152 (100)
Marital status, n (%)
  Not married 196 (25.4) 238 (24.5) 229 (22.7) 381 (42.4) 459 (40.7) 487 (42.3)
  Married 576 (74.6) 734 (75.5) 779 (77.3) 517 (57.6) 669 (59.3) 665 (57.7)
  Total 772 (100) 972 (100) 1008 (100) 898 (100) 1128 (100) 1152 (100)
Hyderabad Nutrition Trial, n (%)
  Control 643 (83.3) 826 (84.9) 835 (82.8) 667 (74.3) 852 (75.5) 865 (75.1)
  Intervention 129 (16.7) 147 (15.1) 173 (17.2) 231 (25.7) 277 (24.5) 287 (24.9)
  Total 772 (100) 973 (100) 1008 (100) 898 (100) 1129 (100) 1152 (100)
  Room temperature 
(°C), mean (SD)
28.7 (3.4) 30.2 (3.4) 30.1 (2.6) 28.3 (3.5) 29.8 (3.2) 29.6 (2.6)
*Characteristics are presented by thirds (low, medium and high level) of ranked NTLI.
APCAPS, Andhra Pradesh Children and Parents Study.
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Comparison with studies using NTLI
Few studies have used NTLI data to explore relationships 
of urbanisation and CVD risk factors. A cross- sectional 
study set in rural and urban Korea (n=8526)46 and a multi-
country study of nationally representative data (n=130 
counties),47 investigated associations of NTLI with BMI. 
Consistent with our results on BMI, increasing level of 
NTLI was associated with rising levels of overweight and 
obesity in both studies. A cross- sectional study from India, 
which analysed NTLI data from NASA’s Visible Infrared 
Imaging Radiometer Suite,48 corroborates our adjusted 
results for SBP, although the included set of covariates 
differed between our studies. We did not find any studies 
on relationships between NTLI and LDL or FPG.
Comparison with studies using multicomponent urbanisation 
scores
Our findings on BMI and SBP agree with cross- sectional 
studies from South India15 (n=3705) and Sri Lanka 
(n=4485),18 which used multicomponent scores to esti-
mate urbanisation levels in multiprovince/state repre-
sentative samples. Although we cannot compare our 
results directly to studies that use urbanisation scores (as 
opposed to NTLI), the direction of effects from low to 
medium (and high) urbanisation levels are consistent 
with our findings from an early- stage urbanisation popu-
lation and support evidence of an association. We found 
no studies exploring relationships between urbanisation 
score and FPG, whereas findings from Sri Lanka18 and 
China49 suggest a greater likelihood of diabetes at high 
but not medium level of urbanisation score (ranging 
from rural areas to large cities). It is possible that we did 
not observe an association of urbanisation level with FPG 
in our study because adverse effects of urbanisation on 
FPG do not manifest until a medium level of urbanisa-
tion is exceeded. However, restricting our analysis to non- 
diabetics may also have contributed to the null results for 
FPG, particularly as excluded individuals were on average 
older and had higher BMI.
Comparison with rural–urban and migrant studies
Measuring urbanisation is challenging, particularly in 
settings where population and environment data are 
sparse.22 As a result, relationships of urbanisation and 
CVD risk factors are often inferred from rural–urban 
comparisons and migrant studies. Several of these studies 
focus on or include Asian populations. An Indian migra-
tion study of 3537 sibling pairs suggests that mean BMI 
is lower among rural than migrant and urban popula-
tions. Patterns were similar for mean SBP, LDL and FPG 
among men but not women.45 In a different analysis of 
the same study, cumulative exposure to urban environ-
ments additionally increased mean BMI of both genders 
as well as SBP and fasting glucose of men, while LDL 
remained unaffected.13 SBP (as the only outcome) was on 
average higher among men than women in our sample; 
however, gender did not modify associations. A cross- 
sectional study from Southern India suggests that mean 
BMI, SBP and the prevalence of diabetes were lower 
among periurban residents of both genders than among 
Figure 2 Crude associations of night- time light intensity (NTLI) with CVD risk factors among APCAPS adults, 2010–2012 
(n=5937). Model predicted means were derived from multilevel linear regression with clustering by household and village, using 
individual- level outcome data. Marker size proportional to village size. APCAPS, Andhra Pradesh Children and Parents Study; 
BMI, body mass index; CVD, cardiovascular disease; FPG, asting plasma glucose; LDL, low- density lipoprotein; SBP, systolic 
blood pressure.
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town and city dwellers.50 Urban versus rural residence 
was also associated with higher prevalence of diabetes49 
and mean LDL in China51 after adjusting for important 
confounders. Two large studies from 568 and 3652 coun-
tries (n=878 000 and 148 579, respectively) across Africa, 
the Middle East, Asia, Americas, the Caribbean and USA 
suggest that overweight (BMI ≥25 kg/m2) is considerably 
more common among urban than rural women, partic-
ularly in lower income countries.8 In a subsample from 
India (n=7608), the prevalence of overweight was almost 
fivefold among urban (26.4 %) compared with rural 
women (5.6 %).52
Strengths and limitation
A major contribution of our study to the existing evidence 
was exploring CVD risk factors in a transitioning popula-
tion in early- stage urbanisation, that is, 27 rural villages 
that have experienced rapid and uneven urbanisation 
over time and thus represented a continuum of urbani-
sation levels from rural settlement to medium size town 
at the time of survey in 2010–2012. The village- level 
NTLI has been validated as a standardised and compa-
rable proxy of urbanisation level, reflecting extent of 
build- up area, population density, economic activity 
and energy consumption worldwide.24–27 It may further 
be a more objective measure than the survey- based data 
used for multiple- component urbanisation scales, which 
are at risk of both interviewer and reporting biases. The 
NTLI data have gained popularity for exploring associ-
ations of urbanisation level and artificial light at night 
with human health, particularly cancer,53–61 overweight 
and obesity.46 47 62 The NTLI time series has further 
been suggested a valid proxy for urbanisation dynamics 
over time,24 27 especially in rapidly developing coun-
tries with high urban growth rates such as China, India 
and Brazil.27 Recent efforts to calibrate the NTLI time 
series has shown great promise for studying urbanisation 
dynamics in these settings28 and offer a unique resource 
for health research worldwide. We calibrated the NTLI 
data using a robust and reliable semiautomatic method 
to reduce systematic bias from satellite discrepancies and 
enable more efficient and precise comparisons of results 
between studies from different regions and time points.28 
However, the semiautomatic method could introduce 
new bias from manual processing.28 The overall agree-
ment of our result with existing evidence (using different 
measures of urbanisation level) supports the utility of 
NTLI to predict urbanisation- related changes in CVD risk 
factors. An important limitation of our study was use of 
a village level exposure with individual- level outcomes. 
Future studies could reduce the potential for bias related 
to the ecological fallacy by allowing for intrasettlement 
variations in NTLI. The large sample size and use of hier-
archical statistical methods should reduce overestimation 
of the magnitude of associations from risk factor clus-
tering by sampling units (villages and households). The 
comparisons of excluded and included participants did 
however warrant some caution of generalising the results T
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to the general population. Trained field and clinical staff 
followed standardised protocols and collected informa-
tion in the local language. A comprehensive list of factors 
were measured and explored as potential confounders 
and effect modifiers in our study; however, some residual 
confounding from unmeasured factors may remain. Data 
for a number of covariates were self- reported, and some 
recall or reporting bias cannot be rule out. We did not 
adjust our results for sociodemographic factors such as 
socioeconomic status, education and occupation because 
these were considered important factors on the causal 
pathway between urbanisation and CVD risk factors in 
the current population, who remained at early stages of 
urbanisation. Most urbanisation in India has predomi-
nantly been driven by the reclassification of rural settle-
ments as they grow and develop.38 Although adversity in 
rural areas, for example, poor opportunities for education 
and paid work, also contribute to urban growth through 
internal migration in India, the migration flow is mainly 
from rural to highly urbanised areas.38 63 The 27 villages 
analysed in the current study remained at early stages of 
urbanisation and represented a continuum from rural 
settlement to medium- sized town. We hypothesised that 
participants who, for example, pursued better education 
or work opportunities, migrated out of the study area (to 
urban areas or abroad) were lost to follow- up and did not 
confound the results by migrating to higher urbanisation 
level villages within the study area. We believe that the 
contribution of sociodemographic factors, such as socio-
economic status, education and occupation, to the associ-
ation of urbanisation on CVD risk factors in populations 
in early- stage urbanisation should be investigated using 
causal methods. Finally, the cross- sectional design of the 
present study prevented us from inferring causality of the 
results as well as from exploring the relative contribution 
of different urbanisation elements to CVD risk.
Hypothesised pathways linking urbanisation and CVD risk 
factors
There are a number of plausible pathways through which 
urbanisation may deteriorate cardiovascular health. Phys-
ical and build environments change with urbanisation 
and in turn influence the level of exposure to noise and 
air pollution, green spaces and infrastructure.22 48 64 65 
Urbanisation is also associated with changes in occupa-
tion patterns and socioeconomic status15 64; social norms, 
cohesion and support; as well as personal tastes and 
preferences.22 48 65 Together with increased availability, 
access and advertising of commodities, these transitions 
promote lifestyle changes that are strongly associated 
with CVD risk, for example, ‘nutrition transition’ towards 
diets high in fat, sugar and salt as well as processed and 
convenience foods; physical inactivity during work, leisure 
time, transport and household chores; and tobacco use 
and alcohol consumption.9 18 22 64 66 Cumulative exposure 
to urban environments additionally appears to increase 
CVD risk.13 17 Recent studies suggest that increased expo-
sure to artificial light at night observed with increasing 
urbanisation level supresses melatonin production, 
disrupts circadian rhythm and leads to physiological and 
behavioural changes associated with CVD.47 A number 
of studies focusing on artificial light at night (other than 
NTLI) without accounting for urbanisation support this 
mechanism.54 67–72 At the same time, greater level of 
urbanisation is also associated with a number of changes 
that may improve CVD health. Greater level of urbanisa-
tion is associated with greater levels and higher quality 
of education; improved opportunities for paid work, 
particularly for women; higher socioeconomic status and 
better living conditions; and better access to health, social 
services and safe food, which have great potential to 
improve cardiovascular health.73–78 Although these path-
ways have been studied extensively, no study has to our 
knowledge attempted to quantify their relative harmful 
and beneficial contributions.
Implications
Our findings indicate that the harmful impacts of 
increasing urbanisation level on SBP and BMI, well- 
established leading modifiable risk factors for CVDs, 
outweigh any beneficial impacts even with moderate 
increases in urbanisation level. These findings suggest an 
opportunity for policy makers and urban planners to help 
curb expected increases in urbanisation- related CVDs by 
addressing underlying and immediate risk factors for 
elevated SBP and BMI during early stages of urbanisation. 
We will however need to understand better and quantify 
the implicated pathways in different settings in order to 
identify cost- effective prevention strategies.
CONCLUSION
We found that the NTLI data, a novel measure of urban-
isation, is a useful tool to predict changes in important 
urbanisation- related CVD risk factors where objective 
data on urbanisation factors are not readily available. The 
observed consistent associations of moderate increases 
in urbanisation level (measured by NTLI) with CVD 
risk factors provide an important early warning for the 
potential progression of the CVD burden in South India 
with continued urbanisation. To curb expected large 
public health impacts from continued and rapid urban-
isation in India, further research is warranted to identify 
the most important mechanisms. To enable targeting of 
cost- effective prevention strategies, we suggest that future 
studies focus on transitioning populations and use causal 
methods to better understand potentially important 
pathways.
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